chloroquine has been researched along with phenacetin in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (56.52) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 6 (26.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Debuch, H; Lepthin, J; Tjiong, HB | 1 |
| Akintonwa, DA | 1 |
| Mukhtar, H; Murti, CR; Sahib, MK | 1 |
| Mukhtar, H; Murti, CR | 1 |
| Klebanov, BM; Trinus, FP | 1 |
| Hazleman, BL | 1 |
| Edwards, A; Gupta, JD; Harley, JD | 1 |
| Buchanan, WW; Dick, WC | 1 |
| Post, D | 1 |
| Jaros, Z | 1 |
| BOUMA, HG; DEVRIES, K; JANSZ, A; NIEWEG, HO | 1 |
| FORD, DK | 1 |
2 review(s) available for chloroquine and phenacetin
| Article | Year |
|---|---|
[Biochemical mechanisms of the action of non-steroid anti-inflammatory agents (literature review)].
Topics: Adenosine Triphosphate; Aminopyrine; Animals; Anti-Inflammatory Agents; Aspirin; Bradykinin; Carboxy-Lyases; Chloroquine; Chymotrypsin; Glucose-6-Phosphate Isomerase; Histamine; Histidine; Indomethacin; Kallidin; Kinins; Lactates; Mefenamic Acid; Oxidative Phosphorylation; Peptide Hydrolases; Phenacetin; Phenylbutazone; Quinolines; Rats; Sodium Salicylate | 1972 |
Advances in the treatment of rheumatic disorders.
Topics: Acetaminophen; Analgesics; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Chloroquine; Female; Flufenamic Acid; Gold; Humans; Immunosuppression Therapy; Indomethacin; Injections, Intra-Articular; Male; Mefenamic Acid; Pentazocine; Phenacetin; Phenylbutazone; Prednisolone; Propionates | 1971 |
21 other study(ies) available for chloroquine and phenacetin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
IARC monographs on the evaluation of the carcinogenic risk of chemicals to man: some miscellaneous pharmaceutical substances.
Topics: Acriflavine; Animals; Anthralin; Aurothioglucose; Carcinogens; Chloroquine; Diazepam; Ethanolamines; Ethionamide; Female; Humans; Hycanthone; Male; Metronidazole; Neoplasms; Neoplasms, Experimental; Oxazepam; Oxymetholone; Oxyphenbutazone; Oxyquinoline; Phenacetin; Phenobarbital; Phenylbutazone; Phenytoin; Pregnancy; Pyrimethamine; Risk | 1977 |
Lysosomal phospholipids from rat liver after treatment with different drugs.
Topics: Acid Phosphatase; Animals; Chloroquine; Hexestrol; Liver; Lysophosphatidylcholines; Lysosomes; Phenacetin; Phosphatidic Acids; Phospholipids; Rats | 1978 |
The derivation of nitrosamines from some therapeutic amines in the human environment.
Topics: Amines; Carcinogens; Chemical Phenomena; Chemistry; Chloroquine; Chlorpromazine; Humans; Methadone; Mixed Function Oxygenases; Nitrosamines; Pharmaceutical Preparations; Phenacetin; Primaquine | 1985 |
Stabilization of rat liver tyrosine aminotransferase by drugs.
Topics: Animals; Chloroquine; Drug Stability; Enzyme Induction; Liver; Male; Mercaptopurine; Phenacetin; Protein Biosynthesis; Rats; Stimulation, Chemical; Tetracycline; Tyrosine; Tyrosine Transaminase | 1973 |
Induction of rat liver tyrosine aminotransferase by pharmacologically unrelated drugs.
Topics: Animals; Azaguanine; Chloroquine; Chlorpromazine; Enzyme Induction; Liver; Mercaptopurine; Phenacetin; Rats; Tetracycline; Tyrosine Transaminase | 1971 |
Drug treatment of connective tissue disease.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Aspirin; Azathioprine; Chloroquine; Collagen Diseases; Cyclophosphamide; Gold; Humans; Immunosuppressive Agents; Indomethacin; Penicillamine; Phenacetin; Phenylbutazone | 1974 |
Photomicrographic evaluation of drug-induced cataracts in cultured embryonic chick lens.
Topics: Animals; Cataract; Chick Embryo; Chloroquine; Culture Media; Culture Techniques; Hydroquinones; Lens, Crystalline; Naphthols; Naphthoquinones; Ouabain; Phenacetin; Phenobarbital; Phenylbutazone; Phenylhydrazines; Photomicrography; Prednisolone; Primaquine; Pyrogallol; Sulfanilamides; Vitamin K | 1973 |
[Documentation in the toxicological laboratory. Practical identification of substances by means of punched feature cards].
Topics: Child; Chloroquine; Chromatography, Thin Layer; Coumarins; Forensic Medicine; Humans; Indicators and Reagents; Pharmaceutical Preparations; Phenacetin; Punched-Card Systems; Spectrum Analysis; Ultraviolet Rays | 1969 |
[Influence of drugs used in rheumatology on the blood].
Topics: Analgesics; Anti-Inflammatory Agents; Bone Marrow Diseases; Chloroquine; Corticosterone; Gold; Hematologic Diseases; Hemorrhage; Humans; Indomethacin; Phenacetin; Phenylbutazone; Salicylates | 1971 |
HAEMATOLOGICAL SIDE-EFFECTS OF SOME ANTI-RHEUMATIC DRUGS.
Topics: Aminopyrine; Antirheumatic Agents; Aspirin; Blood Platelets; Chloroquine; Colchicine; Complement Fixation Tests; Drug Hypersensitivity; Gold; Humans; Hydroxychloroquine; Meprobamate; Phenacetin; Phenylbutazone; Probenecid; Purpura; Purpura, Thrombocytopenic; Quinacrine; Rheumatic Diseases; Splenectomy; Toxicology | 1963 |
NON-STEROID ANTIRHEUMATIC DRUGS.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Rheumatoid; Aspirin; Biomedical Research; Chloroquine; Codeine; Drug Therapy; Gold; Leukocyte Count; Oxyphenbutazone; Phenacetin; Phenylbutazone; Rheumatic Fever; Toxicology | 1964 |